Related Experiment Video
Updated: Sep 27, 2025

An In Vitro Approach to Photodynamic Therapy
Published on: August 17, 2018
5-aminolevulinic acid-photodynamic therapy as a potential approach for kerion
Fangfang Zhang1, Sisi Wang2, Dongmei Li3
1College of Clinical Medicine, Jining Medical University, Jining, Shandong 272000, China; Department of Dermatology, Jining Dermatosis Prevention and Treatment Hospital, Jining, Shandong 272000, China.
Abstract:
Kerion is an inflammatory variant of tinea capitis that is caused by ringworm fungi (zoophilic dermatophytes). It often effects prepubertal children. Classically,antifungals are primarily used as therapeutic agents to treat kerion. However, many patients do not respond well to these agents and severe hepatotoxic side reactions may occur with the long-term use of such drugs. New therapeutic approaches are needed. Here, we report a juvenile case of kerion successfully treated by ALA-PDT (5-aminolevulinic acid-photodynamic therapy) after the failure of a 4-week course of itraconazole and terbinafine. We find three published cases of kerion in the literature, all of which were successfully cured by application of ALA-PDT, highlighting a potentially superior therapeutic choice for kerion treatment.

